ATC code D10
ATC code D10 Anti-acne preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup D10 is part of the anatomical group D Dermatologicals. Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QD10. National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
== D10A Anti-acne preparations for topical use ==
=== D10AA Corticosteroids, combinations for treatment of acne === D10AA01 Fluorometholone D10AA02 Methylprednisolone D10AA03 Dexamethasone
=== D10AB Preparations containing sulfur === D10AB01 Bithionol D10AB02 Sulfur D10AB03 Tioxolone D10AB05 Mesulfen
=== D10AD Retinoids for topical use in acne === D10AD01 Tretinoin D10AD02 Retinol D10AD03 Adapalene D10AD04 Isotretinoin D10AD05 Motretinide D10AD06 Trifarotene D10AD51 Tretinoin, combinations D10AD53 Adapalene, combinations D10AD54 Isotretinoin, combinations
=== D10AE Peroxides === D10AE01 Benzoyl peroxide D10AE51 Benzoyl peroxide, combinations
=== D10AF Anti-infectives for treatment of acne === D10AF01 Clindamycin D10AF02 Erythromycin D10AF03 Chloramphenicol D10AF04 Meclocycline D10AF05 Nadifloxacin D10AF06 Sulfacetamide D10AF07 Minocycline D10AF51 Clindamycin, combinations D10AF52 Erythromycin, combinations
=== D10AX Other anti-acne preparations for topical use === D10AX01 Aluminium chloride D10AX02 Resorcinol D10AX03 Azelaic acid D10AX04 Aluminium oxide D10AX05 Dapsone D10AX06 Clascoterone D10AX30 Various combinations
== D10B Anti-acne preparations for systemic use ==
=== D10BA Retinoids for treatment of acne === D10BA01 Isotretinoin
=== D10BX Other anti-acne preparations for systemic use === D10BX01 Ichtasol
== References ==
Wikipedia contributors, "ATC code D10", Wikipedia, revision 1363027459, retrieved 20 November 2026, source, CC BY-SA 4.0.